New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents
Abstract
A class of diagnostic and therapeutic compounds derived from phosphinimines that include ligands containing either a single phosphinimine functionality or both a phosphinimine group and a phosphine or arsine group, or an aminato group, or a second phosphinimine moiety. These phosphinimine ligands are complexed to early transition metal radionuclides (e.g. .sup.99m Tc or .sup.186 Re/.sup.188 Re) or late transition metals (e.g., .sup.105 Rh or .sup.109 Pd). The complexes with these metals .sup.186 Re/.sup.188 Re, .sup.99m Tc and .sup.109 Pd exhibit a high in vitro and high in vivo stability. The complexes are formed in high yields and can be neutral or charged. These ligands can also be used to form stable compounds with paramagnetic transition metals (e.g. Fe and Mn) for potential use as MRI contrast agents. Applications for the use of ligands and making the ligands are also disclosed.
- Inventors:
-
- Columbia, MO
- Issue Date:
- Research Org.:
- Univ. of Missouri, Columbia, MO (United States)
- OSTI Identifier:
- 870821
- Patent Number(s):
- 5601800
- Assignee:
- Curators of University of Missouri (Columbia, MO)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07B - GENERAL METHODS OF ORGANIC CHEMISTRY
- DOE Contract Number:
- FG02-89ER60875
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- multifunctional; ligands; potential; design; therapeutic; diagnostic; radiopharmaceutical; imaging; agents; compounds; derived; phosphinimines; containing; single; phosphinimine; functionality; phosphine; arsine; aminato; moiety; complexed; transition; metal; radionuclides; 99m; tc; 186; 188; metals; 105; 109; pd; complexes; exhibit; vitro; vivo; stability; formed; yields; neutral; charged; form; stable; paramagnetic; mn; mri; contrast; applications; disclosed; form stable; imaging agents; transition metals; transition metal; stable compound; radiopharmaceutical imaging; imaging agent; contrast agents; contrast agent; therapeutic compounds; multifunctional ligand; diagnostic radiopharmaceutical; /424/999/
Citation Formats
Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, and Singh, Prahlad R. New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents. United States: N. p., 1997.
Web.
Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, & Singh, Prahlad R. New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents. United States.
Katti, Kattesh V, Volkert, Wynn A, Ketring, Alan R, and Singh, Prahlad R. Wed .
"New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents". United States. https://www.osti.gov/servlets/purl/870821.
@article{osti_870821,
title = {New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents},
author = {Katti, Kattesh V and Volkert, Wynn A and Ketring, Alan R and Singh, Prahlad R},
abstractNote = {A class of diagnostic and therapeutic compounds derived from phosphinimines that include ligands containing either a single phosphinimine functionality or both a phosphinimine group and a phosphine or arsine group, or an aminato group, or a second phosphinimine moiety. These phosphinimine ligands are complexed to early transition metal radionuclides (e.g. .sup.99m Tc or .sup.186 Re/.sup.188 Re) or late transition metals (e.g., .sup.105 Rh or .sup.109 Pd). The complexes with these metals .sup.186 Re/.sup.188 Re, .sup.99m Tc and .sup.109 Pd exhibit a high in vitro and high in vivo stability. The complexes are formed in high yields and can be neutral or charged. These ligands can also be used to form stable compounds with paramagnetic transition metals (e.g. Fe and Mn) for potential use as MRI contrast agents. Applications for the use of ligands and making the ligands are also disclosed.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1997},
month = {1}
}
Works referenced in this record:
Radiopharmaceuticals for imaging myocardial perfusion
journal, April 1990
- Nunn, A. D.
- Seminars in Nuclear Medicine, Vol. 20, Issue 2
The Radiobiology of Targeted Radiotherapy
journal, January 1990
- Wheldon, T. E.; O'Donoghue, J. A.
- International Journal of Radiation Biology, Vol. 58, Issue 1
Advances in contrast-enhanced MR imaging. Principles.
journal, February 1991
- Saini, S.
- American Journal of Roentgenology, Vol. 156, Issue 2
Synthesis and in vivo testing of a bromobutyl substituted 1,2-dithia-5,9-diazacycloundecane: a versatile precursor for new 99mTc-bis(aminoethanethiol) complexes
journal, January 1989
- Eisenhut, M.; Brandau, W.; Miβfeldt, M.
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 16, Issue 8
Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy
journal, September 1991
- DiZio, James P.; Fiaschi, Rita; Davison, Alan
- Bioconjugate Chemistry, Vol. 2, Issue 5
Novel bifunctional linkers for antibody chelation with radiometals
book, January 1990
- Wu, Robert Sundoro
- Cancer Imaging with Radiolabeled Antibodies
Preparation and structural characterization of salts of oxotetrachlorotechnetate(V)
journal, November 1979
- Cotton, F. Albert; Davison, Alan; Day, Victor W.
- Inorganic Chemistry, Vol. 18, Issue 11
Some triphenylphosphinimine complexes of zinc, cadmium, mercury, rhodium and palladium
journal, January 1979
- Abel, Edward W.; Mucklejohn, Stuart A.
- Inorganica Chimica Acta, Vol. 37
The Chemistry of Phosphinimines
journal, January 1981
- Abel, E. W.; Mucklejohn, S. A.
- Phosphorus and Sulfur and the Related Elements, Vol. 9, Issue 3
Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent
journal, July 1985
- Moi, Min K.; Meares, Claude F.; McCall, Michael J.
- Analytical Biochemistry, Vol. 148, Issue 1
Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies: Radionuclide selection and dose calculations for labeled antibodies
journal, September 1984
- Wessels, Barry W.; Rogus, Ronald D.
- Medical Physics, Vol. 11, Issue 5
Covalent attachment of chelating groups to macromolecules
journal, July 1977
- Krejcarek, Gary E.; Tucker, Karen L.
- Biochemical and Biophysical Research Communications, Vol. 77, Issue 2
Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents
journal, April 1990
- Krishnamurthy, Gerbail T.; Turner, Fredrick E.
- Seminars in Nuclear Medicine, Vol. 20, Issue 2
Stabilization of rhodium(I)- and iridium(I)-alkyl bonds by intramolecular coordination of an iminophosphorane. X-ray crystal structure of [Rh(CH2PPh2:NC6H4CH3-4)(COD)]
journal, May 1991
- Imhoff, Pieter; Nefkens, Sylvia C. A.; Elsevier, Cornelis
- Organometallics, Vol. 10, Issue 5
2 The clinical use of somatostatin analogues in the treatment of cancer
journal, March 1990
- Lamberts, Steven W. J.; Krenning, Eric P.; Klijn, Jan G. M.
- Baillière's Clinical Endocrinology and Metabolism, Vol. 4, Issue 1
The chemistry of 99mTc-labeled radiopharmaceuticals
journal, January 1990
- Dewanjee, Mrinal K.
- Seminars in Nuclear Medicine, Vol. 20, Issue 1
High oxidation state technetium and rhenium complexes of hydrotris(1-pyrazolyl)borate
journal, December 1991
- Thomas, John Anthony; Davison, Alan
- Inorganica Chimica Acta, Vol. 190, Issue 2
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.
journal, June 1988
- Fritzberg, A. R.; Abrams, P. G.; Beaumier, P. L.
- Proceedings of the National Academy of Sciences, Vol. 85, Issue 11
Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography
journal, October 1990
- Kung, Hank F.; Ohmomo, Yoshiro; Kung, Mei-Ping
- Seminars in Nuclear Medicine, Vol. 20, Issue 4
Production and Use of Prospective Radionuclides for Radioimmunotherapy
book, January 1988
- Mausner, Leonard F.; Straub, Rita F.; Srivastava, Suresh C.
- Radiolabeled Monoclonal Antibodies for Imaging and Therapy
Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies
journal, January 1991
- Srivastava, Suresh C.; Mease, Ronnie C.
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 18, Issue 6
Radiolabeled Phosphonic acid Chelates: Potential Therapeutic Agents for Treatment of Skeletal Metastases
journal, January 1989
- Volkert, W. A.; Simon, J.; Ketring, A. R.
- Drugs of the Future, Vol. 14, Issue 8
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine
journal, January 1986
- Deutsch, Edward; Libson, Karen; Vanderheyden, Jean-Luc
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 13, Issue 4
Chelates and antibodies: Current methods and new directions
book, January 1990
- Gansow, Otto A.; Brechbiel, Martin W.; Mirzadeh, Saed
- Cancer Imaging with Radiolabeled Antibodies
Gd-DPTA: an i.v. contrast agent for clinical MRI
journal, January 1988
- Runge, Val M.
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 15, Issue 1
Transition Metal Chemistry of a Novel and Versatile Heterodifunctional Phosphorus-Nitrogen Ligand System
journal, May 1990
- Katti, K. V.; Cavell, R. G.
- Comments on Inorganic Chemistry, Vol. 10, Issue 2-3
Technetium-99m spiperone dithiocarbamate: A potential radiopharmaceutical for dopamine receptor imaging with SPECT
journal, January 1989
- Ballinger, James R.; Gulenchyn, Karen Y.; Hassan, Mohamed N.
- International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, Vol. 40, Issue 6
Tumour targeting with radiolabelled macrocycle–antibody conjugates
journal, January 1990
- Parker, David
- Chem. Soc. Rev., Vol. 19, Issue 3
Interposition of different chemical linkages between antibody and 111In-DTPA to accelerate clearance from non-target organs and blood
journal, January 1989
- Paik, Chang H.; Quadri, Syed M.; Reba, Richard C.
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 16, Issue 5
Bifunctional chelating agents for radiometal-labeled monoclonal antibodies
book, January 1990
- Subramanian, Ramaswamy; Meares, Claude F.
- Cancer Imaging with Radiolabeled Antibodies